Purchase Order 80NSSC25PB825
Award Date
8/26/25
Potential Completion Date
9/25/25
Potential Value
$54K
Federal Agency
Shared Services Center
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
7E20 - IT and Telecom - End User: Help Desk;Tier 1-2,Workspace,Print,Output,Productivity Tools (HW/Perp SW)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Hampton, VA 23681, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $12,550.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the license and warranty of a GridION sequencing device, with an ultimate completion date of August 1, 2025. Oxford Nanopore Technologies has secured numerous federal contract awards to supply next-generation genomic sequencing equipment, consumables, and associated...
This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for $15,000.00 and does not have a set-aside designation. It provides for the delivery of Oxford Nanopore's GridION Standard Support, which includes their nanopore-based electronic systems for analyzing single molecules such as DNA, RNA, and proteins. This contract supports...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $12,500.00 firm-fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for a 12-month software license and device warranty on a GridION system. The award period runs from August 9, 2021, to August 8, 2022, and does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a provider of nanopore-based...
This is a $12,500 firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. federal government, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit company. The one-year contract is for the LICENSE AND WARRANTY GRIDLON, a next-generation DNA/RNA sequencing system and associated services. The award has no set-aside designation. Oxford Nanopore Technologies has secured numerous prime federal contracts and subcontracts from agencies...
This is a $95,435 firm-fixed-price purchase order (contract) awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the supply of NANOPORE - GRIDION, a next-generation genomic sequencing platform. There is no set-aside designation associated with this award. Oxford Nanopore Technologies Inc. has...
This $12,500.00 firm fixed-price purchase order was awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract provides a GridION license and warranty for the NHLBI's DNA Sequencing and Genomics Core Facility, with a period of performance from March 17, 2025, to March 16, 2026. Oxford Nanopore Technologies Inc. is a prime...
The National Heart, Lung and Blood Institute's DNA Sequencing and Genomics Core awarded a $12,500 firm fixed price purchase order to Oxford Nanopore Technologies Inc. to provide a GridION license and warranty for the sequencing device identified as GXB03004. As a foreign owned, for-profit organization, Oxford Nanopore Technologies Inc. develops nanopore sequencing technology and delivers the GridION and PromethION sequencing platforms, MINION flow cells, and complementary reagents and kits to...
This is a $21,835.00 firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The purpose of the award is to provide a reagent needed by Shelise Brooks for the preparation of direct RNA libraries for sequencing on the Oxford Nanopore Promethion system in support of the Collins NF_Isletbetacells project led by Dr. Mike Erdos at NHGRI. The contract...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases to Oxford Nanopore Technologies Inc. for an annual software license and support renewal for the GridION platform. The potential value of this contract is $12,500.00, and it has a completion date of May 21, 2025. Oxford Nanopore Technologies Inc. is a foreign-owned, for-profit biotechnology company that develops...
This is a $150,000.00 firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for a license and warranty for a PromethION 48 DNA/RNA sequencing system, with a period of performance through October 27, 2029. Oxford Nanopore Technologies has secured multiple prime contracts and...